Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 34 studies with search of: | "Carcinosarcoma" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma
|
||||
2 | Recruiting |
Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors
|
||||
3 | Active, not recruiting |
Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Carcinosarcoma
|
||||
4 | Active, not recruiting |
Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus
|
||||
5 | Recruiting |
Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer
|
||||
6 | Recruiting |
Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer
|
||||
7 | Active, not recruiting |
Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer
|
||||
8 | Active, not recruiting |
Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer
|
||||
9 | Completed |
Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus
|
||||
10 | Active, not recruiting |
Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer
|
||||
11 | Active, not recruiting |
Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus
|
||||
12 | Active, not recruiting |
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus
|
||||
13 | Recruiting |
Pazopanib in Treating Patients With Metastatic Soft Tissue Sarcoma That Has Relapsed or Not Responded to Treatment
|
||||
14 | Completed |
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract
|
||||
15 | Recruiting |
VEGF Trap in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
|
||||
16 | Active, not recruiting |
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
|
||||
17 | Active, not recruiting |
Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma
|
||||
18 | Completed |
Thalidomide in Treating Patients With Gynecologic Sarcomas
|
||||
19 | Active, not recruiting |
Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma
|
||||
20 | Recruiting |
Sunitinib in Treating Patients With Recurrent or Metastatic Endometrial Cancer
|
Previous Page | Studies Shown (1-20) | Next (21-34) |